Europe's drug insurers try pay-for-performance

Article Abstract:

Pharmaceutical firms are adopting pay-for-performance programs to counteract the increasing reluctance of Europe 's state-run health systems to pay for new medicines. Johnson and Johnson has announced that it will reimburse the UK 's National Health Service and France's national health care service if patients do not benefit from certain drugs. GlaxoSmithKline PLC is also discussing pay-for-performance with France 's health care service. Pharmaceutical companies are offering this arrangement to avoid demands for price cuts by health insurers.

Europe, Strategy & planning, Financial management, Services introduction, New Products/Services, Drugs Reimbursement Benefits, United Kingdom, Planning, Finance, United Kingdom. National Health Service, Company service introduction, Service introduction, Prescription drug plans, Johnson & Johnson, Company business planning, Company financing, JNJ, GlaxoSmithKline PLC

---

FDA seeks more study of Novartis medication

Article Abstract:

Although the U.S. Food and Drug Administration has sent an approval letter to Swiss pharmaceutical company Novartis AG for its diabetes medication Galvus, further testing is required before final approval. This will delay the introduction of Galvus by approximately one year.

Product development, Product information, Government regulation, Switzerland, Testing, Novartis AG, Drug therapy, Diabetes, Diabetes mellitus, Licensing, certification and accreditation, United States. Food and Drug Administration, NVTSY, Galvus (Medication)

---

Similar abstracts:

• Abstracts: Peugeot's profit falls 83 percent as sales of autos decline. Renault profit falls 25% on costs, weak demand
• Abstracts: China lures foreign retailers with rule changes. Inditex issues rosy outlook
• Abstracts: Paring golden parachutes. Airbus seeks union support; justifying job cuts may prove critical to allaying anger
• Abstracts: Deutsche Borse is exiting Euronext chase. Deutsche Boerse stays in Euronext race but may seek deal with smaller player
• Abstracts: Virgin Media postpones sale plans. Portugal Telecom investors should call bluff on buyout bid

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.